1. Home
  2. ITOS vs GDOT Comparison

ITOS vs GDOT Comparison

Compare ITOS & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • GDOT
  • Stock Information
  • Founded
  • ITOS 2011
  • GDOT 1999
  • Country
  • ITOS United States
  • GDOT United States
  • Employees
  • ITOS N/A
  • GDOT N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • GDOT Finance: Consumer Services
  • Sector
  • ITOS Health Care
  • GDOT Finance
  • Exchange
  • ITOS Nasdaq
  • GDOT Nasdaq
  • Market Cap
  • ITOS 568.2M
  • GDOT 602.1M
  • IPO Year
  • ITOS 2020
  • GDOT 2010
  • Fundamental
  • Price
  • ITOS $14.80
  • GDOT $10.57
  • Analyst Decision
  • ITOS Strong Buy
  • GDOT Hold
  • Analyst Count
  • ITOS 5
  • GDOT 4
  • Target Price
  • ITOS $32.60
  • GDOT $10.75
  • AVG Volume (30 Days)
  • ITOS 330.6K
  • GDOT 374.8K
  • Earning Date
  • ITOS 11-05-2024
  • GDOT 08-08-2024
  • Dividend Yield
  • ITOS N/A
  • GDOT N/A
  • EPS Growth
  • ITOS N/A
  • GDOT N/A
  • EPS
  • ITOS N/A
  • GDOT N/A
  • Revenue
  • ITOS $35,000,000.00
  • GDOT $1,574,307,000.00
  • Revenue This Year
  • ITOS $271.18
  • GDOT N/A
  • Revenue Next Year
  • ITOS N/A
  • GDOT $9.86
  • P/E Ratio
  • ITOS N/A
  • GDOT N/A
  • Revenue Growth
  • ITOS N/A
  • GDOT 7.36
  • 52 Week Low
  • ITOS $8.20
  • GDOT $7.30
  • 52 Week High
  • ITOS $18.75
  • GDOT $14.83
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 36.33
  • GDOT 50.43
  • Support Level
  • ITOS $17.12
  • GDOT $10.74
  • Resistance Level
  • ITOS $17.44
  • GDOT $11.48
  • Average True Range (ATR)
  • ITOS 0.88
  • GDOT 0.33
  • MACD
  • ITOS -0.21
  • GDOT -0.06
  • Stochastic Oscillator
  • ITOS 4.03
  • GDOT 12.38

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

Share on Social Networks: